Aggressive Shorting
Braveheart Bio (BRVE) continues to face intense short-selling pressure, with short interest as a percentage of free float rising from 36.8% to 43.5% this week. This increase comes despite the stock hitting new all-time lows, signaling that bears remain undeterred and are actively adding to their positions.
Liquidity and Days to Cover
The days-to-cover ratio has expanded significantly from 9.9 to 12.5, indicating that the position is becoming increasingly difficult to unwind. While the stock saw a 7% bump on Friday following Phase 2 data announcements, it remains down 38% year-to-date, reflecting the ongoing struggle to regain investor confidence.
Signal data sourced from TipRanks. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.